{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:44:27Z","timestamp":1753868667805,"version":"3.41.2"},"reference-count":25,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Reports"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Therapeutic effect and immunosuppressor cell alteration in adding transcatheter arterial chemoembolization (TACE) to sorafenib for advanced stage hepatocellular carcinoma (HCC) remain unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>To examine the therapeutic effect and immunosuppressor cell alteration in adding TACE to sorafenib.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Forty\u2010four advanced stage HCC patients were divided into group A (n = 17) treated by sorafenib (400\u2010600\u2009mg\/day) alone and group B patients (n = 27) treated by sorafenib and TACE. The frequency of regulatory T\u2010cells and myeloid\u2010derived suppressor cells (MDSC), and patients' outcomes were examined. Advanced HCC patients' survival was improved by adding TACE to sorafenib if N\/L was reduced from \u22652.5 to &lt;2.5 by TACE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The median (interquartile) follow\u2010up for all patients was 8.5 (3.5 to 15.5) with a range from 1 to 71\u2009months. The median (interquartile) survival was 5.0 (2.3\u201011.3) months for group A and 11.0 (5.0\u201019.0) months for group B patients (<jats:italic>P<\/jats:italic> = .024). In group A, the patients (n = 8) with neutrophil\u2010to\u2010lymphocytes ratio (N\/L)\u2009&lt;\u20092.5 had better survival than the patients (n = 9) with N\/L\u2009\u2265\u20092.5 (<jats:italic>P<\/jats:italic> = .006). In group B, 6 of 13 patients with N\/L\u2009\u2265\u20092.5 had N\/L reduction to &lt;2.5 after combination therapy of sorafenib and TACE, and their 6\u2010month, 1\u2010year and 2\u2010year survival were improved (<jats:italic>P<\/jats:italic> = .013). For immune cell examination, the frequency of CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T\u2010lymphocytes, regulatory T\u2010cell and MDSC were not altered by sorafenib treatment. However, actual number of lymphocytes had a tendency to increase (from 978.5\u2009\u00b1\u2009319.4\/mm<jats:sup>3<\/jats:sup> prior to treatment to 1378.0\u2009\u00b1\u2009403.3\/mm<jats:sup>3<\/jats:sup>, <jats:italic>P<\/jats:italic> = .086) for the patients with N\/L reduction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Immunosuppressor cells were not altered by sorafeinb. Patients' survival was improved if N\/L\u2009\u2265\u20092.5 was reduced to &lt;2.5 by TACE.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cnr2.1294","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T19:16:26Z","timestamp":1602616586000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Treatment strategy of adding transcatheter arterial chemoembolization to sorafenib for advanced stage hepatocellular carcinoma"],"prefix":"10.1002","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8627-1324","authenticated-orcid":false,"given":"Wei\u2010Chen","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Liver and Transplantation Surgery, Department of General Surgery Chang\u2010Gung Memorial Hospital  Linkou Taiwan"},{"name":"Department of Medicine Chang\u2010Gung University College of Medicine  Taoyuan Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao\u2010Chien","family":"Hung","sequence":"additional","affiliation":[{"name":"Division of Liver and Transplantation Surgery, Department of General Surgery Chang\u2010Gung Memorial Hospital  Linkou Taiwan"},{"name":"Department of Medicine Chang\u2010Gung University College of Medicine  Taoyuan Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin\u2010Chiao","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Liver and Transplantation Surgery, Department of General Surgery Chang\u2010Gung Memorial Hospital  Linkou Taiwan"},{"name":"Department of Medicine Chang\u2010Gung University College of Medicine  Taoyuan Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2010Chao","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Liver and Transplantation Surgery, Department of General Surgery Chang\u2010Gung Memorial Hospital  Linkou Taiwan"},{"name":"Department of Medicine Chang\u2010Gung University College of Medicine  Taoyuan Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih\u2010Hsien","family":"Cheng","sequence":"additional","affiliation":[{"name":"Division of Liver and Transplantation Surgery, Department of General Surgery Chang\u2010Gung Memorial Hospital  Linkou Taiwan"},{"name":"Department of Medicine Chang\u2010Gung University College of Medicine  Taoyuan Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsung\u2010Han","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Liver and Transplantation Surgery, Department of General Surgery Chang\u2010Gung Memorial Hospital  Linkou Taiwan"},{"name":"Department of Medicine Chang\u2010Gung University College of Medicine  Taoyuan Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen\u2010Fang","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Liver and Transplantation Surgery, Department of General Surgery Chang\u2010Gung Memorial Hospital  Linkou Taiwan"},{"name":"Department of Medicine Chang\u2010Gung University College of Medicine  Taoyuan Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting\u2010Jung","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Liver and Transplantation Surgery, Department of General Surgery Chang\u2010Gung Memorial Hospital  Linkou Taiwan"},{"name":"Department of Medicine Chang\u2010Gung University College of Medicine  Taoyuan Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong\u2010Shiue","family":"Chou","sequence":"additional","affiliation":[{"name":"Division of Liver and Transplantation Surgery, Department of General Surgery Chang\u2010Gung Memorial Hospital  Linkou Taiwan"},{"name":"Department of Medicine Chang\u2010Gung University College of Medicine  Taoyuan Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun\u2010Ming","family":"Chan","sequence":"additional","affiliation":[{"name":"Division of Liver and Transplantation Surgery, Department of General Surgery Chang\u2010Gung Memorial Hospital  Linkou Taiwan"},{"name":"Department of Medicine Chang\u2010Gung University College of Medicine  Taoyuan Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1323.2001.02034.x"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2010.02.010"},{"key":"e_1_2_11_4_1","first-page":"207","article-title":"Hepatocellular carcinoma: natural history, current management, and emerging tools","volume":"6","author":"Tinkle CL","year":"2012","journal-title":"Biol Targets Ther"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1247128"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30010-2"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12664-018-0915-0"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70285-7"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31044-9"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2010.07.006"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31046-2"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1642"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2008.11.007"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2506"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040895"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-010-0855-8"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.498"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12818"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-60"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.11.029"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.025"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01322"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181a77e59"},{"key":"e_1_2_11_25_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/4743808","article-title":"Elevated preoperative neutrophil\u2010lymphocyte ratio is associated with poor prognosis in hepatocellular carcinoma patients treated with liver transplantation: a meta\u2010analysis","volume":"2016","author":"Sun XD","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-117"}],"container-title":["Cancer Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cnr2.1294","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cnr2.1294","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cnr2.1294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T04:35:38Z","timestamp":1693715738000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cnr2.1294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1002\/cnr2.1294"],"URL":"https:\/\/doi.org\/10.1002\/cnr2.1294","archive":["Portico"],"relation":{},"ISSN":["2573-8348","2573-8348"],"issn-type":[{"type":"print","value":"2573-8348"},{"type":"electronic","value":"2573-8348"}],"subject":[],"published":{"date-parts":[[2020,10,13]]},"assertion":[{"value":"2020-04-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e1294"}}